Earlier this year, President Obama and Congress decided to spend more than a billion health care dollars for something known as "comparative effectiveness" research. The research involves side-by-side ...
Comparative effectiveness research has been the target of recurrent criticism in some political circles, with opponents claiming it’s the “gateway to rationing” or it encourages “cookbook medicine.” ...
Show More 1 Division of Pharmaceutical Outcomes and Policy, University of North Carolina (UNC) Eshelman School of Pharmacy, Chapel Hill, NC Eligible patients had one or more fills for imatinib, ...
The complexity of glycemic management in type 2 diabetes mellitus (T2DM) has increased dramatically in the past 15 years. In 1995, the drugs available for treatment of T2DM were insulin and ...
A Publicly Reported Health Outcomes program is intended to provide health quality comparisons of health plans and provider organizations to purchasers, government officials, and the general public. In ...
Cost-effectiveness analysis of pharmacokinetic-guided (PK) 5-fluorouracil (5FU) when combined with leucovorin and oxaliplatin (FOLFOX) chemotherapy for metastatic colorectal cancer (mCRC). Association ...
Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...
Accuracy and honesty are critical to the patient-doctor relationship, yet studies show that up to 38 percent of patients concealed significant facts when undergoing medical treatment. Accuracy and ...
FIRST DIRECT MAIL. Former U.S. Rep. John Delaney, after raising his profile by debating health care and other issues with progressive Sens. Bernie Sanders and Elizabeth Warren on Tuesday, wasted no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results